ACTAVIA LIFE SCIENCES, INC.
ACTAVIA LIFE SCIENCES, INC. (RASP): 3 pipeline candidates · ~0 mo cash runway. Updated within the last hour.
BioSniper Score
4-factor signal · derived from public data
0.1 months
0% dilution
Lead: Preclinical
3 candidates
N/A
N/A
A transparent, data-derived signal for ACTAVIA LIFE SCIENCES, INC.across cash runway, pipeline maturity & breadth, catalyst momentum and clinical/regulatory footprint. Each factor traces to tracked public filings — not an investment recommendation.
Key Financials
Market Cap
$386K
Cash
$1K
Quarterly Burn
$36K
Runway
0.1 mo
Revenue
—
Cash Runway vs Catalysts
Tracked catalysts land within the current projected cash runway.
Pipeline (3 candidates)
Frequently asked questions
How many drug candidates are in ACTAVIA LIFE SCIENCES, INC.'s pipeline?
ACTAVIA LIFE SCIENCES, INC. (RASP) has 3 pipeline candidates tracked by BioSniper across SEC filings and clinical trial registrations.
What is ACTAVIA LIFE SCIENCES, INC.'s lead drug candidate?
ACTAVIA LIFE SCIENCES, INC.'s most advanced tracked candidate is rasp-101 (Preclinical) for Acute myeloid leukemia (AML).
What is ACTAVIA LIFE SCIENCES, INC.'s cash runway?
Based on its most recent reported cash balance and quarterly burn rate, ACTAVIA LIFE SCIENCES, INC. has approximately 0.1 months of cash runway.
What is ACTAVIA LIFE SCIENCES, INC.'s market capitalization?
ACTAVIA LIFE SCIENCES, INC.'s market capitalization is approximately $386K.
Get the full picture on ACTAVIA LIFE SCIENCES, INC.
Deep pipeline analysis, financial trends, AI-powered investment signals, and real-time catalyst alerts.